IDiyas

For the Inventor, By the Inventor

Bonn, Germany

Michael Szimtenings

USPTO Granted Patents = 7

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:

goldMedal7 out of 30,028 
 
Siemens Aktiengesellschaft
 patents

Years Active: 2012-2017

Loading Chart...
7 patents (USPTO):Explore Patents
1. 9636422 - Method for detecting a brain region with neurodegenerative change (2017-05-02),
2. 8547094 - Method for determining an attenuation map for use with positron emission tomography and magnetic resonance magnetic field homogeneity from a single three dimensional gradient echo sequence (2013-10-01),
3. 8467845 - Method for data acquisition and/or data evaluation during a functional brain examination with the aid of a combined magnetic resonance/PET unit (2013-06-18),
4. 8452378 - Method for determining attenuation values for PET data of a patient (2013-05-28),
5. 8362769 - Magnetic resonance method and device to automatically differentiate water-dominated and fat-dominated tissue with only one spin echo acquired for each pixel (2013-01-29),
6. 8195417 - Method for recording measured data from a patient by taking movements into account, and associated medical device (2012-06-05),
7. 8180128 - Method for recording measured data of a patient while taking account of movement operations, and an associated medical device (2012-05-15),

Title: Michael Szimtenings: Innovator in Neuroimaging Technologies

Introduction

Michael Szimtenings is a prominent inventor based in Bonn, Germany. He has made significant contributions to the field of neuroimaging, particularly in the detection of neurodegenerative changes in the brain. With a total of 7 patents to his name, Szimtenings continues to push the boundaries of medical imaging technology.

Latest Patents

One of his latest patents is a method for detecting a brain region with neurodegenerative change. This computerized method involves recording brain data through positron emission tomography (PET) and magnetic resonance imaging (MRI). The process includes reconstructing images from both data records, identifying brain regions with vascular changes, and superposing the images to determine the presence of neurodegenerative changes in gray or white matter.

Another notable patent is a method for determining an attenuation map for use with positron emission tomography and magnetic resonance magnetic field homogeneity. This method utilizes a single three-dimensional gradient echo sequence to record image data at different echo times. The attenuation map is derived from fat/water ratios obtained through Dixon technology, enhancing the accuracy of imaging in clinical settings.

Career Highlights

Michael Szimtenings is currently employed at Siemens Aktiengesellschaft, a leading company in the field of medical technology. His work at Siemens has allowed him to develop innovative solutions that improve diagnostic capabilities in neuroimaging.

Collaborations

Throughout his career, Szimtenings has collaborated with talented professionals, including Diana Martin and Thorsten Feiweier. These collaborations have fostered an environment of innovation and have contributed to the advancement of neuroimaging technologies.

Conclusion

Michael Szimtenings is a key figure in the field of neuroimaging, with a focus on developing methods that enhance the detection of brain changes. His contributions through patents and collaborations continue to impact the medical imaging landscape significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…